Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 3, 2003, Pages 1367-1373

  Wild, Anja ^a   Ramaswamy, Annette ^a   Langer, Peter ^a   Celik, Ilhan ^a   Fendrich, Volker ^a   Chaloupka, Brunhilde ^a   Simon, Babette ^a   Bartsch, Detlef K ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ALLELE; ARTICLE; CARCINOGENESIS; CHROMOSOME 22Q; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; ENDOCRINE TUMOR; GASTRINOMA; GENE LOCATION; GENE SILENCING; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULINOMA; METASTASIS; MOLECULAR MECHANICS; PANCREAS TUMOR; PANCREATIC ENDOCRINE TUMOR; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA ANALYSIS; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE; VIPOMA; ZOLLINGER ELLISON SYNDROME;

DNA METHYLATION; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; PANCREATIC NEOPLASMS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 0037341622     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021027     Document Type: Article

References (38)

1. Klöppel G, Intveld PA, Stamm B, Heitz PU 1990 The endocrine pancreas. In: Kovacs K, Asa SL, eds. Functional endocrine pathology. Boston: Blackwell Scientific Publications; 396-421
2. Zhuang Z, Vortmeyer AO, Pack S, Huang S, Pham TA, Wang C, Park WS, Agarwal SK, Debelenko LV, Kester M, Guru SC, Manickam P, Olufemi SE, Yu F, Heppner C, Crabtree JS, Skarulis MC, Venzon DJ, Emmert-Buck MR, Spiegel AM, Chandrasekharappa SC, Collins FS, Burns AL, Marx SJ, Lubensky IA 1997 Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 57:4682-4686
3. Shan L, Nakamura Y, Nakamura M, Yokoi T, Tsujimoto M, Arima R, Kameya T, Kakudo K 1998 Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors. Lab Invest 78:471-475
4. Yoshimoto K, Iwahana H, Fukuda A, Sano T, Katsuragi K, Kinoshita M, Saito S, Itakura M 1992 ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism. Jpn J Cancer Res 83:1057-1062
5. Yashiro T, Fulton N, Hara H, Yasuda K, Montag A, Yashiro N, Straus 2nd F, Ito K, Aiyoshi Y, Kaplan EL 1993 Comparison of mutations of ras oncogene in human pancreatic exocrine and endocrine tumors. Surgery 114:758-764
6. Moore PS, Orlandini S, Zamboni G, Capelli P, Rigaud G, Falconi M, Bassi C, Lemoine NR, Scarpa A 2000 Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br J Cancer 84:253-262
7. Yoshimoto K, Iwahana H, Fukuda A, Sano T, Katsuragi K, Saito S, Itakura M 1992 Role of p53 mutations in endocrine tumorigenesis. Cancer Res 53:1057-1062
8. Muscarella P, Melvin WS, Fisher WE, Foor J, Ellison EC, Herman JG, Schirmer WJ, Hitchcock CL, DeYoung BR, Weghorst CM 1998 Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: an analysis of p16/MTS1 tumor suppressor gene inactivation. Cancer Res 58:237-240
9. Serrano J, Goebel SU, Peghini PL, Lubensky IA, Gibril F, Jensen RT 2000 Alterations in the p16INK4a/CDKN2A tumor suppressor gene in gastrinomas. J Clin Endocrinol Metab 85:4146-4156
10. Bartsch DK, Kersting M, Wild A, Ramaswamy A, Gerdes B, Schuermann M, Simon B, Rothmund M 2000 Low frequency of p16(INK4a) alterations in insulinomas. Digestion 62:171-177
11. Bartsch DK, Hahn SA, Danichevski KD, Ramaswamy A, Bastian D, Galedhari H, Barth P, Schmiegel W, Simon B, Rothmund M 1999 Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors. Oncogene 18:2367-2371
12. Perren A, Komminoth P, Saremaslani P, Matter C, Feurer S, Lees JA, Heitz PU, Eng C 2000 Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol 157:1097-1103
13. Ebrahimi SA, Wang EH, Wu A, Schreck RR, Passaro Jr E, Sawicki MP 1999 Deletion of chromosome 1 predicts prognosis in pancreatic endocrine tumors. Cancer Res 59:311-315
14. Chung DC, Smith AP, Louis DN, Graeme-Cook F, Warshaw A, Arnold A 1997 A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. J Clin Invest 100:404-410
15. Nikiforova MN, Nikiforov YE, Biddiger P, Gnepp DR, Grosembacher LA, Wajchenberg BL, Fagin JA, Cohen RM 1999 Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours. Clin Endocrinol (Oxf) 51:27-33
16. Hessman O, Lindberg D, Einarsson A, Lillhager P, Carling T, Grimelius L, Eriksson B, Akerström G, Westin G, Skogseid B 1999 Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors. Genes Chromosomes Cancer 26:258-264
17. Rigaud G, Missiaglia E, Moore PS, Zamboni G, Falconi M, Talamini G, Pesci A, Baron A, Lissandrini D, Rindi G, Grigolato P, Pederzoli P, Scarpa A 2001 High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res 61:285-292
18. Chung DC, Brown SB, Graeme-Cook F, Tillotson LG, Warshaw AL, Jensen RT, Arnold A 1998 Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors. Cancer Res 57:3706-3711
19. Wild A, Langer P, Ramaswamy A, Chaloupka B, Bartsch DK 2001 A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications. J Clin Endocrinol Metab 86:5782-5787
20. Wild A, Langer P, Celik I, Chaloupka B, Bartsch DK 2002 Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions. Eur J Endocrinol 147:1-7
21. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP 1997 Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74:111-122
22. Anand-Apte B, Bao L, Smith R, Iwata K, Olsen BR, Zetter B, Apte SS 1996 A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem Cell Biol 74:853-862
23. Chambers AF, Matrisian LM 1997 Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89:1260-1270
24. Ahonen M, Baker AH, Kahari VM 1998 Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 58:2310-2315
25. Baker AH, George SJ, Zaltsman AB, Murphy G, Newby AC 1999 Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br J Cancer 79:1347-1355
26. Bachman KE, Herman JG, Corn PG, Merlo A, Costello JF, Cavenee WK, Baylin SB, Graff JR 1999 Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res 59:798-802
27. Langer P, Bartsch DK, Gerdes B, Schwetlick I, Wild A, Erley C, Lamberts R 2002 Renin producing neuroendocrine pancreatic carcinoma - a case report and review of the literature. Exp Clin Endocrinol Diabetes 110:43-49
28. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB 1996 Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826
29. Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH, Goggins M 2000 Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 60:1835-1839
30. Bian J, Wang Y, Smith MR, Kim H, Jacobs C, Jackman J, Kung HF, Colburn NH, Sun Y 1996 Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloprotemases (TIMP)-3. Carcinogenesis 17:1805-1811
31. Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD 2001 Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 61:249-255
32. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG 2001 CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 61:2847-2851
33. Felbor U, Suvanto EA, Forsius HR, Eriksson AW, Weber BHF 1997 Autosomal recessive Sorsby fundus dystrophy revisited: molecular evidence for dominant inheritance. Am J Hum Genet 60:57-62
34. Ayyagari R, Griesinger IB, Bingham E, Lark KK, Moroi SE, Sieving PA 2000 Autosomal dominant hemorrhagic macular dystrophy not associated with the TIMP3 gene. Arch Ophthalmol 118:85-92
35. Prosser J 1993 Detecting single-base mutations. Trends Biotechnol 11:238-247
36. Nataraj AJ, Olivos-Glander I, Kusukawa N, Highsmith Jr WE 1999 Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detection. Electrophoresis 20:1177-1185
37. Stumpf E, Aalto Y, Hoog A, Kjellman M, Otonkoski T, Knuutila S, Andersson LC 2000 Chromosomal alterations in human pancreatic endocrine tumors. Genes Chromosomes Cancer 29:83-87
38. Speel EJ, Scheidweiler AF, Zhao J, Matter C, Saremaslani P, Roth J, Heitz PU, Komminoth P 2001 Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas. Cancer Res 61:5186-5192